171 related articles for article (PubMed ID: 29928423)
1. Expression and clinical significance of miR-23a and MTSS1 in diffuse large B-cell lymphoma.
Xu M; Xu T
Oncol Lett; 2018 Jul; 16(1):371-377. PubMed ID: 29928423
[TBL] [Abstract][Full Text] [Related]
2. LncRNA MALAT1 promotes tumorigenesis and immune escape of diffuse large B cell lymphoma by sponging miR-195.
Wang QM; Lian GY; Song Y; Huang YF; Gong Y
Life Sci; 2019 Aug; 231():116335. PubMed ID: 30898647
[TBL] [Abstract][Full Text] [Related]
3. [Expression and clinical significance of miR-23a and metastasis suppressor 1 in colon carcinoma].
Tang HL; Deng M; Liao QJ; Zeng X; Zhou XT; Su Q
Zhonghua Bing Li Xue Za Zhi; 2012 Jan; 41(1):28-32. PubMed ID: 22455847
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance and detection of microRNA-21 in serum of patients with diffuse large B-cell lymphoma in Chinese population.
Chen W; Wang H; Chen H; Liu S; Lu H; Kong D; Huang X; Kong Q; Lu Z
Eur J Haematol; 2014; 92(5):407-12. PubMed ID: 24400911
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-23a expression in paraffin-embedded specimen correlates with overall survival of diffuse large B-cell lymphoma.
Wang WL; Yang C; Han XL; Wang R; Huang Y; Zi YM; Li JD
Med Oncol; 2014 Apr; 31(4):919. PubMed ID: 24659264
[TBL] [Abstract][Full Text] [Related]
6. [Expression of miR-126 in Diffuse Large B-Cell Lymphoma and Its Biological Function].
Qiu C; Zhang QH; Wang GG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Oct; 30(5):1415-1422. PubMed ID: 36208243
[TBL] [Abstract][Full Text] [Related]
7. [Mechanism of MiR-224 Affecting DLBCL Cell Proliferation and Invasion by Targeted Inhibition of PIK3CD].
Xie Y; Tan L; Li YT; Zeng Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Oct; 28(5):1578-1584. PubMed ID: 33067957
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-181a Inhibits Activated B-Cell-Like Diffuse Large B-Cell Lymphoma Progression by Repressing
Zhu D; Fang C; He W; Wu C; Li X; Wu J
J Oncol; 2019; 2019():9832956. PubMed ID: 31662757
[TBL] [Abstract][Full Text] [Related]
9. [Expression of MiR-155 in Tissue of Patients with Diffuse Large B-Cell Lymphoma and Its Effect on Cell Biological Characteristics].
Han B; Gao ZD; Wang HX; Wang ZH; Fan CB; Liu JL; Tian M; Zhao HG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Apr; 27(2):445-451. PubMed ID: 30998152
[TBL] [Abstract][Full Text] [Related]
10. MDM2-P53 Signaling Pathway-Mediated Upregulation of CDC20 Promotes Progression of Human Diffuse Large B-Cell Lymphoma.
Sun C; Li M; Feng Y; Sun F; Zhang L; Xu Y; Lu S; Zhu J; Huang J; Wang J; Hu Y; Zhang Y
Onco Targets Ther; 2020; 13():10475-10487. PubMed ID: 33116627
[TBL] [Abstract][Full Text] [Related]
11. Preliminary study on decreasing the expression of FOXP3 with miR-155 to inhibit diffuse large B-cell lymphoma.
Zhang J; Wei B; Hu H; Liu F; Tu Y; Zhao M; Wu D
Oncol Lett; 2017 Aug; 14(2):1711-1718. PubMed ID: 28789399
[TBL] [Abstract][Full Text] [Related]
12. [Potential mechanism and prognostic value of promoter methylation of PRDM1 gene in diffuse large B cell lymphoma].
Zhang XY; Ma ZP; Cui WL; Chen R; Glinaer A; Miao N; Li XX
Zhonghua Bing Li Xue Za Zhi; 2016 Dec; 45(12):831-837. PubMed ID: 28056297
[No Abstract] [Full Text] [Related]
13. [Impact of PRDM1 gene inactivation on C-MYC regulation in diffuse large B-cell lymphoma].
Zhang XY; Ma ZP; Cui WL; Pang XL; Chen R; Wang L; Zhang W; Li XX
Zhonghua Bing Li Xue Za Zhi; 2018 Jan; 47(1):25-31. PubMed ID: 29325247
[No Abstract] [Full Text] [Related]
14. Increased expression of IRF8 in tumor cells inhibits the generation of Th17 cells and predicts unfavorable survival of diffuse large B cell lymphoma patients.
Zhong W; Xu X; Zhu Z; Du Q; Du H; Yang L; Ling Y; Xiong H; Li Q
Oncotarget; 2017 Jul; 8(30):49757-49772. PubMed ID: 28537908
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of heme oxygenase-1 induced by constitutively activated NF-κB as a potential therapeutic target for activated B-cell-like diffuse large B-cell lymphoma.
Huang J; Guo P; Ma D; Lin X; Fang Q; Wang J
Int J Oncol; 2016 Jul; 49(1):253-64. PubMed ID: 27211510
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of UCA1 restrains cell proliferation and metastasis of diffuse large B-cell lymphoma by counteracting miR-331-3p expression.
Zhang M; Du Y; Shang J; Zhang D; Dong X; Chen H
Oncol Lett; 2021 Jan; 21(1):39. PubMed ID: 33262831
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-21 regulates the viability and apoptosis of diffuse large B-cell lymphoma cells by upregulating B cell lymphoma-2.
Liu K; Du J; Ruan L
Exp Ther Med; 2017 Nov; 14(5):4489-4496. PubMed ID: 29067124
[TBL] [Abstract][Full Text] [Related]
18. [The Expression and Correlation of
Li Y; Liu XY; Cui GR; Kong XY; Yang L; Luo JM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Feb; 31(1):120-124. PubMed ID: 36765487
[TBL] [Abstract][Full Text] [Related]
19. Z-VRPR-FMK can inhibit the growth and invasiveness of diffuse large B-cell lymphoma by depressing NF-κB activation and MMP expression induced by MALT1.
Feng J; Yang W; Wang J; Pu Z; Han Y; Wan L
Int J Clin Exp Pathol; 2019; 12(6):1947-1955. PubMed ID: 31934017
[TBL] [Abstract][Full Text] [Related]
20. MiR-223 Suppresses Proliferation and Promotes Apoptosis of Diffuse Large B-Cell Lymphoma Cells Through Lmo2 and MAPK Signaling Pathway.
Zhang Y; Zhang J
J BUON; 2021; 26(2):580-586. PubMed ID: 34077008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
